An insight into orphan diseases and why research into those rare diseases matters!
You may have read “orphan disease” or have seen us using the word. But what are those? Per definition, an orphan disease is defined as a...
At Elastrin, there‘s something new every day.
Elastin Fiber antibodies guide the therapy to where it needs to be
Search
Elastrin Therapeutics
- Apr 7
- 3 min
Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round
Elastrin Therapeutics Inc. closes $10M Funding Round
Elastrin Therapeutics
- Feb 14
- 2 min
Regenerative Medicine – Part 2
The previous article discussed the potential but also the struggles faced by development of therapies in the regenerative medicine...
Elastrin Therapeutics
- Feb 9
- 1 min
Interview with the SC Business Review
We just recently got interviewed by the South Carolina Radio about Elastrin Therapeutics and our InnoVision Award win. Listen now to the...
Elastrin Therapeutics
- Jan 18
- 4 min
Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
GREENVILLE, S.C.--(BUSINESS WIRE)--Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to...
Elastrin Therapeutics
- Jan 4
- 2 min
Regenerative Medicine - Part 1
Regenerative Medicine is an interdisciplinary field that applies engineering and life science techniques to promote the repair or regrowth..
Elastrin Therapeutics
- Dec 19, 2021
- 2 min
The World’s Deadliest Killer: The Heart
The cardiovascular system is an extremely dynamic environment, and its performance heavily relies on the synergies of its main players....
matthiasbreugelman
- Nov 18, 2021
- 1 min
Winner @ InnoVision Awards 2021
We are proud to present that Elastrin Therapeutics has won the 2021 InnoVision Technology Development Award. InnoVision Awards,...
Valentin Busch
- Mar 5, 2021
- 3 min
Elastrin Therapeutics Inc. Closes Seed Funding Round with Kizoo Technology Capital
CLEMSON, S.C. & BERLIN--(BUSINESS WIRE)--Elastrin is a biotechnology startup leveraging a platform technology to develop therapeutics...
Valentin Busch
- Apr 7, 2020
- 2 min
Elastrin develops new approach against “Inflammatory Storm” that kills most Corona patients
A new approach to preventing the most severe outcomes of lung diseases, including COVID-19, has been developed by Elastrin Therapeutics Inc.
Valentin Busch
- Mar 3, 2019
- 1 min
Researchers Reverse Vascular Calcification in Chronic Kidney Disease Animal Model
Clemson University researchers published pre-clinical proof of reversing in lab animals the leading cause of cardiovascular events in...
Valentin Busch
- Jan 12, 2019
- 1 min
CSO Naren Vyavahare receives USD 2.2 million from NIH for nanoparticle research
Elastrin's Chief Scientific Officer Prof. Naren Vyavahare was granted USD 2.2 million from the National Institutes of Health to advance...
Valentin Busch
- Nov 16, 2018
- 1 min
Elastrin Therapeutics receives $25.000 grant by SCRA and is admitted to SC Launch program
The South Carolina Research Authority (SCRA) has granted Elastrin $25.000 in financial support through its Academic Start-up Assistance...
Valentin Busch
- Oct 2, 2018
- 1 min
Elastrin wins Entrepreuner award!
Elastrin Therpapeutics has won the 2018 Xi´an International Entrepreneuship Competition held in Hamburg October 19, 2018 and was selected...